Understanding Sparsentan: A Revolutionary Treatment for IgA Nephropathy
Introduction to Sparsentan Sparsentan represents a significant advancement in the treatment of chronic kidney diseases, particularly primary Immunoglobulin A nephropathy (IgAN). IgAN, also known as Berger’s disease, is the most common form of glomerulonephritis worldwide. This condition leads to the buildup of IgA—a type of antibody—in the kidneys, which can cause inflammation and, over time, […]